0       0

AMDA's 2015 Annual Conference


B55 - Quality Prescribing Campaign: Preventing Adverse Drug Events and Collaborating with your Consultant Pharmacist (An ASCP Sponsored Session)


Mar 20, 2015 4:00pm ‐ Mar 20, 2015 5:00pm


Credits: None available.

Standard: $24.00

Description

Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this Internet Enduring Material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABPLM Designation Statement: This Internet Enduring Material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1 clinical hour toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM.  Each physician should claim only those hours of credit actually spent on the activity.

Session Description:
AMDA has launched a Quality Prescribing Campaign in response to CMS's Call to Action: Raising Awareness for Reducing Adverse Events (ADE) in Nursing Homes. This session will focus on raising awareness specifically directed toward adverse drug events around three major groups of medications. One major tenet of AMDA's Quality prescribing campaign relies on teamwork. The active presence and involvement of patients, family members, prescribers, pharmacists, nurses, therapists and others involved in care working together is essential to help people feel better and do more. In the spirit of collaborative teamwork, this session will present tools and tips that address safer use of these drugs, and effective communication and coordination of care. The focus on the three initial targets of the National Action Plan for ADE will be anticoagulants, diabetes agents, and opioids.

Learning Objective(s):

  • Identify ways that members of interdisciplinary can collaborate to improve quality and prevent adverse drug events
  • Recognize medication specific steps to improve care and prevent adverse drug events
  • Discuss pitfalls/barriers to care that lead to adverse drug events
  • Describe how to employ quality prescribing methods to prevent adverse drug events

Speaker(s):
Sharon Clackum, PharmD, CGP, FASCP

Disclosure(s):
None

Reference(s):
None

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content